| Autor: |
Jørgensen, H., Anderssen, N., Silsand, T., Peterson, L.-E. |
| Zdroj: |
Journal of International Medical Research; November 1989, Vol. 17 Issue: 6 p552-559, 8p |
| Abstrakt: |
The effect of 30 mg/day slow-release frusemide given orally for 12 months was studied in 64 patients previously treated with thiazides for mild to moderate essential hypertension. Frusemide had a significant antihypertensive effect (P<0.001), and compared to thiazides significantly reduced fasting serum glucose (P<0.015), haemoglobin A1c(P<0.025), albumin (P<0.025) and serum calcium (P<0.025), and significantly increased serum sodium and chloride concentrations (P<0.0001). There was also a non-significant trend for frusemide to reduce serum total cholesterol, triglycerides and urate, and to increase serum potassium. Frusemide was well tolerated in all but three patients. It is concluded that slow-release frusemide has a comparable antihypertensive effect to that of thiazide diuretics, but has fewer metabolic side-effects, and should be used in preference to thiazides for the treatment of arterial hypertension when a diuretic is indicated. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
